Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Cell and Developmental Biology"
DOI: 10.3389/fcell.2022.1048360
Abstract: The role of the intestinal microbiota in the promotion, progression, and response to therapies is gaining importance, but recent studies confirm the presence of microbiota also in the tumor, thus becoming a component of the… read more here.
Keywords: microbiota; tumor resident; response therapies; resident microbiota ... See more keywords
The SUMO Pathway in Hematomalignancies and Their Response to Therapies
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms20163895
Abstract: SUMO (Small Ubiquitin-related MOdifier) is a post-translational modifier of the ubiquitin family controlling the function and fate of thousands of proteins. SUMOylation is deregulated in various hematological malignancies, where it participates in both tumorigenesis and… read more here.
Keywords: sumoylation; pathway hematomalignancies; response; hematomalignancies response ... See more keywords